nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ALB—multiple sclerosis	0.226	1	CbGaD
Abiraterone—Testosterone—Prednisolone—multiple sclerosis	0.207	1	CrCrCtD
Abiraterone—CYP17A1—Dexamethasone—multiple sclerosis	0.114	0.274	CbGbCtD
Abiraterone—ABCC1—Mitoxantrone—multiple sclerosis	0.0752	0.18	CbGbCtD
Abiraterone—CYP2D6—Fingolimod—multiple sclerosis	0.0364	0.0872	CbGbCtD
Abiraterone—ABCC1—Methotrexate—multiple sclerosis	0.0313	0.0751	CbGbCtD
Abiraterone—ALB—Prednisone—multiple sclerosis	0.0288	0.069	CbGbCtD
Abiraterone—CYP3A4—Fingolimod—multiple sclerosis	0.0231	0.0554	CbGbCtD
Abiraterone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0149	0.0357	CbGbCtD
Abiraterone—ALB—Methotrexate—multiple sclerosis	0.0145	0.0346	CbGbCtD
Abiraterone—CYP2C8—Dexamethasone—multiple sclerosis	0.0139	0.0333	CbGbCtD
Abiraterone—CYP3A4—Triamcinolone—multiple sclerosis	0.0113	0.0271	CbGbCtD
Abiraterone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0109	0.0261	CbGbCtD
Abiraterone—CYP3A4—Betamethasone—multiple sclerosis	0.00969	0.0232	CbGbCtD
Abiraterone—CYP3A4—Prednisolone—multiple sclerosis	0.00956	0.0229	CbGbCtD
Abiraterone—CYP3A4—Prednisone—multiple sclerosis	0.00903	0.0216	CbGbCtD
Abiraterone—CYP2D6—Dexamethasone—multiple sclerosis	0.00886	0.0212	CbGbCtD
Abiraterone—CYP3A4—Dexamethasone—multiple sclerosis	0.00564	0.0135	CbGbCtD
Abiraterone—SULT2A1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00152	0.0414	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00145	0.0395	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00145	0.0395	CbGpPWpGaD
Abiraterone—ABCC1—S1P1 pathway—S1PR1—multiple sclerosis	0.00128	0.0348	CbGpPWpGaD
Abiraterone—ABCC1—Sphingosine 1-phosphate (S1P) pathway—S1PR1—multiple sclerosis	0.00118	0.0321	CbGpPWpGaD
Abiraterone—SULT2A1—E2F transcription factor network—RRM1—multiple sclerosis	0.00109	0.0299	CbGpPWpGaD
Abiraterone—CYP17A1—Glucocorticoid biosynthesis—POMC—multiple sclerosis	0.00101	0.0276	CbGpPWpGaD
Abiraterone—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000896	0.0245	CbGpPWpGaD
Abiraterone—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000896	0.0245	CbGpPWpGaD
Abiraterone—CYP17A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000885	0.0242	CbGpPWpGaD
Abiraterone—CYP17A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000885	0.0242	CbGpPWpGaD
Abiraterone—CYP17A1—Androgen biosynthesis—POMC—multiple sclerosis	0.000783	0.0214	CbGpPWpGaD
Abiraterone—ABCC1—Irinotecan Pathway—BCHE—multiple sclerosis	0.000754	0.0206	CbGpPWpGaD
Abiraterone—SULT2A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000727	0.0199	CbGpPWpGaD
Abiraterone—SULT2A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000727	0.0199	CbGpPWpGaD
Abiraterone—CYP17A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000727	0.0198	CbGpPWpGaD
Abiraterone—CYP17A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000727	0.0198	CbGpPWpGaD
Abiraterone—SULT2A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000717	0.0196	CbGpPWpGaD
Abiraterone—SULT2A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000717	0.0196	CbGpPWpGaD
Abiraterone—Urethral disorder—Cladribine—multiple sclerosis	0.000495	0.00436	CcSEcCtD
Abiraterone—Cardiac failure—Mitoxantrone—multiple sclerosis	0.000491	0.00434	CcSEcCtD
Abiraterone—Fluid retention—Triamcinolone—multiple sclerosis	0.000473	0.00417	CcSEcCtD
Abiraterone—Fluid retention—Methylprednisolone—multiple sclerosis	0.000472	0.00417	CcSEcCtD
Abiraterone—Cardiac disorder—Cladribine—multiple sclerosis	0.000468	0.00413	CcSEcCtD
Abiraterone—Pneumonia—Azathioprine—multiple sclerosis	0.00046	0.00406	CcSEcCtD
Abiraterone—Angiopathy—Cladribine—multiple sclerosis	0.000458	0.00404	CcSEcCtD
Abiraterone—Infestation—Azathioprine—multiple sclerosis	0.000457	0.00403	CcSEcCtD
Abiraterone—Infestation NOS—Azathioprine—multiple sclerosis	0.000457	0.00403	CcSEcCtD
Abiraterone—Mediastinal disorder—Cladribine—multiple sclerosis	0.000455	0.00401	CcSEcCtD
Abiraterone—Asthenia—Fingolimod—multiple sclerosis	0.000454	0.004	CcSEcCtD
Abiraterone—Contusion—Prednisone—multiple sclerosis	0.000451	0.00398	CcSEcCtD
Abiraterone—Arrhythmia—Cladribine—multiple sclerosis	0.000451	0.00398	CcSEcCtD
Abiraterone—Mental disorder—Cladribine—multiple sclerosis	0.000442	0.0039	CcSEcCtD
Abiraterone—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.000436	0.00385	CcSEcCtD
Abiraterone—CYP17A1—Endogenous sterols—POMC—multiple sclerosis	0.000434	0.0119	CbGpPWpGaD
Abiraterone—Diarrhoea—Fingolimod—multiple sclerosis	0.000433	0.00382	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Mitoxantrone—multiple sclerosis	0.000432	0.00381	CcSEcCtD
Abiraterone—Fluid retention—Betamethasone—multiple sclerosis	0.000429	0.00379	CcSEcCtD
Abiraterone—Fluid retention—Dexamethasone—multiple sclerosis	0.000429	0.00379	CcSEcCtD
Abiraterone—Hepatotoxicity—Methotrexate—multiple sclerosis	0.000426	0.00376	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.000423	0.00373	CcSEcCtD
Abiraterone—Hypercholesterolaemia—Prednisone—multiple sclerosis	0.000416	0.00367	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Methylprednisolone—multiple sclerosis	0.000415	0.00366	CcSEcCtD
Abiraterone—Anaemia—Cladribine—multiple sclerosis	0.000406	0.00358	CcSEcCtD
Abiraterone—CYP17A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000386	0.0105	CbGpPWpGaD
Abiraterone—CYP17A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000386	0.0105	CbGpPWpGaD
Abiraterone—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.000385	0.0034	CcSEcCtD
Abiraterone—Cough—Cladribine—multiple sclerosis	0.000383	0.00338	CcSEcCtD
Abiraterone—CYP17A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000381	0.0104	CbGpPWpGaD
Abiraterone—CYP17A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000381	0.0104	CbGpPWpGaD
Abiraterone—Chest pain—Cladribine—multiple sclerosis	0.000374	0.0033	CcSEcCtD
Abiraterone—Myalgia—Cladribine—multiple sclerosis	0.000374	0.0033	CcSEcCtD
Abiraterone—Fluid retention—Prednisone—multiple sclerosis	0.000374	0.0033	CcSEcCtD
Abiraterone—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.000374	0.0033	CcSEcCtD
Abiraterone—Pneumonia—Mitoxantrone—multiple sclerosis	0.000372	0.00328	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000371	0.00328	CcSEcCtD
Abiraterone—Cardiac failure—Methylprednisolone—multiple sclerosis	0.00037	0.00326	CcSEcCtD
Abiraterone—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00037	0.00326	CcSEcCtD
Abiraterone—Discomfort—Cladribine—multiple sclerosis	0.00037	0.00326	CcSEcCtD
Abiraterone—Arrhythmia—Azathioprine—multiple sclerosis	0.000367	0.00323	CcSEcCtD
Abiraterone—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.000364	0.00321	CcSEcCtD
Abiraterone—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.000362	0.0032	CcSEcCtD
Abiraterone—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.000359	0.00317	CcSEcCtD
Abiraterone—Oedema—Cladribine—multiple sclerosis	0.000359	0.00316	CcSEcCtD
Abiraterone—Infection—Cladribine—multiple sclerosis	0.000356	0.00314	CcSEcCtD
Abiraterone—Haematuria—Mitoxantrone—multiple sclerosis	0.000352	0.00311	CcSEcCtD
Abiraterone—Skin disorder—Cladribine—multiple sclerosis	0.000348	0.00307	CcSEcCtD
Abiraterone—Cardiac failure—Dexamethasone—multiple sclerosis	0.000336	0.00297	CcSEcCtD
Abiraterone—Cardiac failure—Betamethasone—multiple sclerosis	0.000336	0.00297	CcSEcCtD
Abiraterone—Anaemia—Azathioprine—multiple sclerosis	0.00033	0.00291	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000327	0.00288	CcSEcCtD
Abiraterone—CYP17A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000325	0.00888	CbGpPWpGaD
Abiraterone—Insomnia—Cladribine—multiple sclerosis	0.000324	0.00286	CcSEcCtD
Abiraterone—Dyspnoea—Cladribine—multiple sclerosis	0.00032	0.00282	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.000318	0.00281	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00031	0.00273	CcSEcCtD
Abiraterone—Fatigue—Cladribine—multiple sclerosis	0.000309	0.00273	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.000308	0.00841	CbGpPWpGaD
Abiraterone—Constipation—Cladribine—multiple sclerosis	0.000307	0.00271	CcSEcCtD
Abiraterone—Myalgia—Azathioprine—multiple sclerosis	0.000304	0.00268	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000302	0.00266	CcSEcCtD
Abiraterone—Discomfort—Azathioprine—multiple sclerosis	0.0003	0.00265	CcSEcCtD
Abiraterone—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000299	0.00264	CcSEcCtD
Abiraterone—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000299	0.00264	CcSEcCtD
Abiraterone—Hypokalaemia—Betamethasone—multiple sclerosis	0.000299	0.00264	CcSEcCtD
Abiraterone—Myocardial infarction—Prednisolone—multiple sclerosis	0.000297	0.00262	CcSEcCtD
Abiraterone—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000296	0.00261	CcSEcCtD
Abiraterone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000295	0.00806	CbGpPWpGaD
Abiraterone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000295	0.00806	CbGpPWpGaD
Abiraterone—Cardiac failure—Prednisone—multiple sclerosis	0.000293	0.00258	CcSEcCtD
Abiraterone—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000291	0.00796	CbGpPWpGaD
Abiraterone—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000291	0.00796	CbGpPWpGaD
Abiraterone—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.000291	0.00256	CcSEcCtD
Abiraterone—Infection—Azathioprine—multiple sclerosis	0.00029	0.00256	CcSEcCtD
Abiraterone—Body temperature increased—Cladribine—multiple sclerosis	0.000283	0.0025	CcSEcCtD
Abiraterone—Skin disorder—Azathioprine—multiple sclerosis	0.000283	0.0025	CcSEcCtD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000279	0.00763	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000279	0.00763	CbGpPWpGaD
Abiraterone—Infestation—Methylprednisolone—multiple sclerosis	0.000278	0.00245	CcSEcCtD
Abiraterone—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000278	0.00245	CcSEcCtD
Abiraterone—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000275	0.00242	CcSEcCtD
Abiraterone—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000274	0.00242	CcSEcCtD
Abiraterone—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000273	0.00241	CcSEcCtD
Abiraterone—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000273	0.00241	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.00027	0.00737	CbGpPWpGaD
Abiraterone—Anaemia—Mitoxantrone—multiple sclerosis	0.000267	0.00235	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000266	0.00234	CcSEcCtD
Abiraterone—Hypokalaemia—Prednisone—multiple sclerosis	0.00026	0.0023	CcSEcCtD
Abiraterone—Asthenia—Cladribine—multiple sclerosis	0.000257	0.00227	CcSEcCtD
Abiraterone—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000256	0.00226	CcSEcCtD
Abiraterone—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000256	0.00226	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000252	0.00222	CcSEcCtD
Abiraterone—Cough—Mitoxantrone—multiple sclerosis	0.000252	0.00222	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000252	0.00222	CcSEcCtD
Abiraterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00025	0.00682	CbGpPWpGaD
Abiraterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00025	0.00682	CbGpPWpGaD
Abiraterone—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000249	0.0022	CcSEcCtD
Abiraterone—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000249	0.0022	CcSEcCtD
Abiraterone—Hypertension—Mitoxantrone—multiple sclerosis	0.000249	0.0022	CcSEcCtD
Abiraterone—Myocardial infarction—Betamethasone—multiple sclerosis	0.000248	0.00219	CcSEcCtD
Abiraterone—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000248	0.00219	CcSEcCtD
Abiraterone—Chest pain—Mitoxantrone—multiple sclerosis	0.000246	0.00217	CcSEcCtD
Abiraterone—Myalgia—Mitoxantrone—multiple sclerosis	0.000246	0.00217	CcSEcCtD
Abiraterone—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000245	0.00217	CcSEcCtD
Abiraterone—Diarrhoea—Cladribine—multiple sclerosis	0.000245	0.00216	CcSEcCtD
Abiraterone—Arrhythmia—Prednisolone—multiple sclerosis	0.000243	0.00215	CcSEcCtD
Abiraterone—Discomfort—Mitoxantrone—multiple sclerosis	0.000243	0.00214	CcSEcCtD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000242	0.00662	CbGpPWpGaD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000242	0.00662	CbGpPWpGaD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000239	0.00654	CbGpPWpGaD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000239	0.00654	CbGpPWpGaD
Abiraterone—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000239	0.00653	CbGpPWpGaD
Abiraterone—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000239	0.00653	CbGpPWpGaD
Abiraterone—Oedema—Mitoxantrone—multiple sclerosis	0.000236	0.00208	CcSEcCtD
Abiraterone—Infection—Mitoxantrone—multiple sclerosis	0.000234	0.00207	CcSEcCtD
Abiraterone—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	0.000233	0.00636	CbGpPWpGaD
Abiraterone—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000232	0.00204	CcSEcCtD
Abiraterone—Body temperature increased—Azathioprine—multiple sclerosis	0.00023	0.00203	CcSEcCtD
Abiraterone—Skin disorder—Mitoxantrone—multiple sclerosis	0.000229	0.00202	CcSEcCtD
Abiraterone—Vomiting—Cladribine—multiple sclerosis	0.000228	0.00201	CcSEcCtD
Abiraterone—Angiopathy—Methylprednisolone—multiple sclerosis	0.000227	0.002	CcSEcCtD
Abiraterone—Rash—Cladribine—multiple sclerosis	0.000226	0.00199	CcSEcCtD
Abiraterone—Dermatitis—Cladribine—multiple sclerosis	0.000226	0.00199	CcSEcCtD
Abiraterone—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000225	0.00199	CcSEcCtD
Abiraterone—Arrhythmia—Triamcinolone—multiple sclerosis	0.000224	0.00197	CcSEcCtD
Abiraterone—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000223	0.00197	CcSEcCtD
Abiraterone—Hyperglycaemia—Prednisone—multiple sclerosis	0.000223	0.00197	CcSEcCtD
Abiraterone—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000221	0.00603	CbGpPWpGaD
Abiraterone—Mental disorder—Methylprednisolone—multiple sclerosis	0.000219	0.00193	CcSEcCtD
Abiraterone—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000217	0.00192	CcSEcCtD
Abiraterone—Myocardial infarction—Prednisone—multiple sclerosis	0.000216	0.00191	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000215	0.00189	CcSEcCtD
Abiraterone—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00021	0.00185	CcSEcCtD
Abiraterone—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000207	0.00183	CcSEcCtD
Abiraterone—Angiopathy—Dexamethasone—multiple sclerosis	0.000206	0.00182	CcSEcCtD
Abiraterone—Angiopathy—Betamethasone—multiple sclerosis	0.000206	0.00182	CcSEcCtD
Abiraterone—Hypertension—Prednisolone—multiple sclerosis	0.000205	0.0018	CcSEcCtD
Abiraterone—Fatigue—Mitoxantrone—multiple sclerosis	0.000203	0.00179	CcSEcCtD
Abiraterone—Arrhythmia—Dexamethasone—multiple sclerosis	0.000203	0.00179	CcSEcCtD
Abiraterone—Arrhythmia—Betamethasone—multiple sclerosis	0.000203	0.00179	CcSEcCtD
Abiraterone—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000202	0.00551	CbGpPWpGaD
Abiraterone—Constipation—Mitoxantrone—multiple sclerosis	0.000202	0.00178	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.0002	0.00545	CbGpPWpGaD
Abiraterone—Diarrhoea—Azathioprine—multiple sclerosis	0.000199	0.00176	CcSEcCtD
Abiraterone—Discomfort—Prednisolone—multiple sclerosis	0.000199	0.00176	CcSEcCtD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000197	0.00537	CbGpPWpGaD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000197	0.00537	CbGpPWpGaD
Abiraterone—Connective tissue disorder—Prednisone—multiple sclerosis	0.000194	0.00171	CcSEcCtD
Abiraterone—Oedema—Prednisolone—multiple sclerosis	0.000193	0.00171	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000192	0.00169	CcSEcCtD
Abiraterone—ALB—Platelet degranulation—PLEK—multiple sclerosis	0.00019	0.00519	CbGpPWpGaD
Abiraterone—Cough—Triamcinolone—multiple sclerosis	0.00019	0.00168	CcSEcCtD
Abiraterone—Hypertension—Triamcinolone—multiple sclerosis	0.000188	0.00166	CcSEcCtD
Abiraterone—SULT2A1—E2F transcription factor network—MYC—multiple sclerosis	0.000188	0.00513	CbGpPWpGaD
Abiraterone—Hypertension—Methylprednisolone—multiple sclerosis	0.000188	0.00166	CcSEcCtD
Abiraterone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000186	0.00164	CcSEcCtD
Abiraterone—Myalgia—Triamcinolone—multiple sclerosis	0.000185	0.00164	CcSEcCtD
Abiraterone—Vomiting—Azathioprine—multiple sclerosis	0.000185	0.00164	CcSEcCtD
Abiraterone—Pneumonia—Methotrexate—multiple sclerosis	0.000185	0.00163	CcSEcCtD
Abiraterone—Myalgia—Methylprednisolone—multiple sclerosis	0.000185	0.00163	CcSEcCtD
Abiraterone—Infestation NOS—Methotrexate—multiple sclerosis	0.000184	0.00162	CcSEcCtD
Abiraterone—Infestation—Methotrexate—multiple sclerosis	0.000184	0.00162	CcSEcCtD
Abiraterone—Rash—Azathioprine—multiple sclerosis	0.000184	0.00162	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000184	0.00162	CcSEcCtD
Abiraterone—Dermatitis—Azathioprine—multiple sclerosis	0.000184	0.00162	CcSEcCtD
Abiraterone—Discomfort—Triamcinolone—multiple sclerosis	0.000183	0.00162	CcSEcCtD
Abiraterone—Discomfort—Methylprednisolone—multiple sclerosis	0.000183	0.00161	CcSEcCtD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000181	0.00495	CbGpPWpGaD
Abiraterone—Angiopathy—Prednisone—multiple sclerosis	0.000179	0.00158	CcSEcCtD
Abiraterone—Oedema—Triamcinolone—multiple sclerosis	0.000178	0.00157	CcSEcCtD
Abiraterone—Arrhythmia—Prednisone—multiple sclerosis	0.000177	0.00156	CcSEcCtD
Abiraterone—Infection—Triamcinolone—multiple sclerosis	0.000177	0.00156	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—SRM—multiple sclerosis	0.000177	0.00482	CbGpPWpGaD
Abiraterone—Infection—Methylprednisolone—multiple sclerosis	0.000176	0.00156	CcSEcCtD
Abiraterone—Haematuria—Methotrexate—multiple sclerosis	0.000176	0.00155	CcSEcCtD
Abiraterone—Insomnia—Prednisolone—multiple sclerosis	0.000175	0.00154	CcSEcCtD
Abiraterone—Mental disorder—Prednisone—multiple sclerosis	0.000173	0.00153	CcSEcCtD
Abiraterone—ABCC1—S1P1 pathway—MAPK1—multiple sclerosis	0.000173	0.00471	CbGpPWpGaD
Abiraterone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000172	0.00152	CcSEcCtD
Abiraterone—Hypertension—Betamethasone—multiple sclerosis	0.000171	0.00151	CcSEcCtD
Abiraterone—Hypertension—Dexamethasone—multiple sclerosis	0.000171	0.00151	CcSEcCtD
Abiraterone—Asthenia—Mitoxantrone—multiple sclerosis	0.000169	0.00149	CcSEcCtD
Abiraterone—Myalgia—Betamethasone—multiple sclerosis	0.000168	0.00148	CcSEcCtD
Abiraterone—Myalgia—Dexamethasone—multiple sclerosis	0.000168	0.00148	CcSEcCtD
Abiraterone—Discomfort—Dexamethasone—multiple sclerosis	0.000166	0.00147	CcSEcCtD
Abiraterone—Discomfort—Betamethasone—multiple sclerosis	0.000166	0.00147	CcSEcCtD
Abiraterone—SULT2A1—Biological oxidations—POMC—multiple sclerosis	0.000164	0.00447	CbGpPWpGaD
Abiraterone—CYP17A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000163	0.00446	CbGpPWpGaD
Abiraterone—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000163	0.00144	CcSEcCtD
Abiraterone—Urethral disorder—Methotrexate—multiple sclerosis	0.000162	0.00143	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000162	0.00143	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000162	0.00143	CcSEcCtD
Abiraterone—Oedema—Betamethasone—multiple sclerosis	0.000161	0.00142	CcSEcCtD
Abiraterone—Oedema—Dexamethasone—multiple sclerosis	0.000161	0.00142	CcSEcCtD
Abiraterone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000161	0.00142	CcSEcCtD
Abiraterone—Insomnia—Triamcinolone—multiple sclerosis	0.000161	0.00142	CcSEcCtD
Abiraterone—Insomnia—Methylprednisolone—multiple sclerosis	0.00016	0.00142	CcSEcCtD
Abiraterone—Infection—Betamethasone—multiple sclerosis	0.00016	0.00141	CcSEcCtD
Abiraterone—Infection—Dexamethasone—multiple sclerosis	0.00016	0.00141	CcSEcCtD
Abiraterone—Anaemia—Prednisone—multiple sclerosis	0.000159	0.0014	CcSEcCtD
Abiraterone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000159	0.0014	CcSEcCtD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000159	0.00433	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000159	0.00433	CbGpPWpGaD
Abiraterone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000157	0.00138	CcSEcCtD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000156	0.00427	CbGpPWpGaD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000156	0.00427	CbGpPWpGaD
Abiraterone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000156	0.00138	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000156	0.00425	CbGpPWpGaD
Abiraterone—Cardiac disorder—Methotrexate—multiple sclerosis	0.000153	0.00135	CcSEcCtD
Abiraterone—Fatigue—Triamcinolone—multiple sclerosis	0.000153	0.00135	CcSEcCtD
Abiraterone—Fatigue—Methylprednisolone—multiple sclerosis	0.000153	0.00135	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000153	0.00417	CbGpPWpGaD
Abiraterone—Angiopathy—Methotrexate—multiple sclerosis	0.00015	0.00132	CcSEcCtD
Abiraterone—Vomiting—Mitoxantrone—multiple sclerosis	0.00015	0.00132	CcSEcCtD
Abiraterone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000149	0.00131	CcSEcCtD
Abiraterone—Hypertension—Prednisone—multiple sclerosis	0.000149	0.00131	CcSEcCtD
Abiraterone—Rash—Mitoxantrone—multiple sclerosis	0.000149	0.00131	CcSEcCtD
Abiraterone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000148	0.00131	CcSEcCtD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000148	0.00405	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000148	0.00405	CbGpPWpGaD
Abiraterone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000147	0.0013	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000147	0.0013	CcSEcCtD
Abiraterone—Myalgia—Prednisone—multiple sclerosis	0.000147	0.00129	CcSEcCtD
Abiraterone—Insomnia—Betamethasone—multiple sclerosis	0.000146	0.00129	CcSEcCtD
Abiraterone—Insomnia—Dexamethasone—multiple sclerosis	0.000146	0.00129	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000146	0.00128	CcSEcCtD
Abiraterone—Discomfort—Prednisone—multiple sclerosis	0.000145	0.00128	CcSEcCtD
Abiraterone—Mental disorder—Methotrexate—multiple sclerosis	0.000145	0.00128	CcSEcCtD
Abiraterone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000142	0.00388	CbGpPWpGaD
Abiraterone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000142	0.00125	CcSEcCtD
Abiraterone—Dyspepsia—Betamethasone—multiple sclerosis	0.000142	0.00125	CcSEcCtD
Abiraterone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000141	0.00124	CcSEcCtD
Abiraterone—Oedema—Prednisone—multiple sclerosis	0.000141	0.00124	CcSEcCtD
Abiraterone—Infection—Prednisone—multiple sclerosis	0.00014	0.00123	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000139	0.00123	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000139	0.00123	CcSEcCtD
Abiraterone—Fatigue—Dexamethasone—multiple sclerosis	0.000139	0.00123	CcSEcCtD
Abiraterone—Fatigue—Betamethasone—multiple sclerosis	0.000139	0.00123	CcSEcCtD
Abiraterone—Skin disorder—Prednisone—multiple sclerosis	0.000136	0.0012	CcSEcCtD
Abiraterone—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	0.000134	0.00365	CbGpPWpGaD
Abiraterone—Anaemia—Methotrexate—multiple sclerosis	0.000133	0.00117	CcSEcCtD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000128	0.00351	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000128	0.00351	CbGpPWpGaD
Abiraterone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000128	0.00113	CcSEcCtD
Abiraterone—Asthenia—Triamcinolone—multiple sclerosis	0.000128	0.00113	CcSEcCtD
Abiraterone—Body temperature increased—Betamethasone—multiple sclerosis	0.000128	0.00113	CcSEcCtD
Abiraterone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000128	0.00113	CcSEcCtD
Abiraterone—Asthenia—Methylprednisolone—multiple sclerosis	0.000127	0.00112	CcSEcCtD
Abiraterone—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000127	0.00347	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000127	0.00347	CbGpPWpGaD
Abiraterone—Insomnia—Prednisone—multiple sclerosis	0.000127	0.00112	CcSEcCtD
Abiraterone—Cough—Methotrexate—multiple sclerosis	0.000126	0.00111	CcSEcCtD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000125	0.00342	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000125	0.00342	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP27B1—multiple sclerosis	0.000124	0.0034	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP24A1—multiple sclerosis	0.000124	0.0034	CbGpPWpGaD
Abiraterone—Dyspepsia—Prednisone—multiple sclerosis	0.000124	0.00109	CcSEcCtD
Abiraterone—Myalgia—Methotrexate—multiple sclerosis	0.000122	0.00108	CcSEcCtD
Abiraterone—Chest pain—Methotrexate—multiple sclerosis	0.000122	0.00108	CcSEcCtD
Abiraterone—Rash—Prednisolone—multiple sclerosis	0.000122	0.00108	CcSEcCtD
Abiraterone—Dermatitis—Prednisolone—multiple sclerosis	0.000122	0.00107	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000122	0.00107	CcSEcCtD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000122	0.00332	CbGpPWpGaD
Abiraterone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000121	0.00107	CcSEcCtD
Abiraterone—Fatigue—Prednisone—multiple sclerosis	0.000121	0.00107	CcSEcCtD
Abiraterone—Discomfort—Methotrexate—multiple sclerosis	0.000121	0.00107	CcSEcCtD
Abiraterone—Constipation—Prednisone—multiple sclerosis	0.00012	0.00106	CcSEcCtD
Abiraterone—Infection—Methotrexate—multiple sclerosis	0.000117	0.00103	CcSEcCtD
Abiraterone—Asthenia—Betamethasone—multiple sclerosis	0.000116	0.00102	CcSEcCtD
Abiraterone—Asthenia—Dexamethasone—multiple sclerosis	0.000116	0.00102	CcSEcCtD
Abiraterone—Skin disorder—Methotrexate—multiple sclerosis	0.000114	0.00101	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—GPC5—multiple sclerosis	0.000114	0.00311	CbGpPWpGaD
Abiraterone—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000114	0.0031	CbGpPWpGaD
Abiraterone—Vomiting—Triamcinolone—multiple sclerosis	0.000113	0.000997	CcSEcCtD
Abiraterone—Vomiting—Methylprednisolone—multiple sclerosis	0.000113	0.000995	CcSEcCtD
Abiraterone—Rash—Triamcinolone—multiple sclerosis	0.000112	0.000989	CcSEcCtD
Abiraterone—Dermatitis—Triamcinolone—multiple sclerosis	0.000112	0.000988	CcSEcCtD
Abiraterone—Rash—Methylprednisolone—multiple sclerosis	0.000112	0.000987	CcSEcCtD
Abiraterone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000112	0.000986	CcSEcCtD
Abiraterone—Body temperature increased—Prednisone—multiple sclerosis	0.000111	0.00098	CcSEcCtD
Abiraterone—Diarrhoea—Betamethasone—multiple sclerosis	0.00011	0.000974	CcSEcCtD
Abiraterone—Diarrhoea—Dexamethasone—multiple sclerosis	0.00011	0.000974	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000107	0.000944	CcSEcCtD
Abiraterone—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.000107	0.00292	CbGpPWpGaD
Abiraterone—Insomnia—Methotrexate—multiple sclerosis	0.000106	0.000937	CcSEcCtD
Abiraterone—Dyspnoea—Methotrexate—multiple sclerosis	0.000105	0.000924	CcSEcCtD
Abiraterone—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000104	0.00285	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000104	0.00285	CbGpPWpGaD
Abiraterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	0.000104	0.00285	CbGpPWpGaD
Abiraterone—Dyspepsia—Methotrexate—multiple sclerosis	0.000103	0.000912	CcSEcCtD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000103	0.00281	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000103	0.00281	CbGpPWpGaD
Abiraterone—Vomiting—Betamethasone—multiple sclerosis	0.000103	0.000905	CcSEcCtD
Abiraterone—Vomiting—Dexamethasone—multiple sclerosis	0.000103	0.000905	CcSEcCtD
Abiraterone—Rash—Dexamethasone—multiple sclerosis	0.000102	0.000898	CcSEcCtD
Abiraterone—Rash—Betamethasone—multiple sclerosis	0.000102	0.000898	CcSEcCtD
Abiraterone—Dermatitis—Betamethasone—multiple sclerosis	0.000102	0.000897	CcSEcCtD
Abiraterone—Dermatitis—Dexamethasone—multiple sclerosis	0.000102	0.000897	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000101	0.000894	CcSEcCtD
Abiraterone—Fatigue—Methotrexate—multiple sclerosis	0.000101	0.000893	CcSEcCtD
Abiraterone—Asthenia—Prednisone—multiple sclerosis	0.000101	0.000889	CcSEcCtD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	9.77e-05	0.00267	CbGpPWpGaD
Abiraterone—Diarrhoea—Prednisone—multiple sclerosis	9.61e-05	0.000848	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—RRM1—multiple sclerosis	9.43e-05	0.00257	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—SRM—multiple sclerosis	9.37e-05	0.00256	CbGpPWpGaD
Abiraterone—Body temperature increased—Methotrexate—multiple sclerosis	9.28e-05	0.000819	CcSEcCtD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.15e-05	0.0025	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.94e-05	0.00244	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.94e-05	0.00244	CbGpPWpGaD
Abiraterone—Vomiting—Prednisone—multiple sclerosis	8.93e-05	0.000788	CcSEcCtD
Abiraterone—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	8.9e-05	0.00243	CbGpPWpGaD
Abiraterone—Rash—Prednisone—multiple sclerosis	8.86e-05	0.000782	CcSEcCtD
Abiraterone—Dermatitis—Prednisone—multiple sclerosis	8.85e-05	0.000781	CcSEcCtD
Abiraterone—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	8.76e-05	0.00239	CbGpPWpGaD
Abiraterone—CYP17A1—Biological oxidations—POMC—multiple sclerosis	8.68e-05	0.00237	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	8.43e-05	0.0023	CbGpPWpGaD
Abiraterone—Asthenia—Methotrexate—multiple sclerosis	8.42e-05	0.000743	CcSEcCtD
Abiraterone—ALB—Folate Metabolism—IL4—multiple sclerosis	8.42e-05	0.0023	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	8.22e-05	0.00225	CbGpPWpGaD
Abiraterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.17e-05	0.00223	CbGpPWpGaD
Abiraterone—Diarrhoea—Methotrexate—multiple sclerosis	8.03e-05	0.000709	CcSEcCtD
Abiraterone—Vomiting—Methotrexate—multiple sclerosis	7.47e-05	0.000659	CcSEcCtD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.41e-05	0.00202	CbGpPWpGaD
Abiraterone—Rash—Methotrexate—multiple sclerosis	7.4e-05	0.000653	CcSEcCtD
Abiraterone—Dermatitis—Methotrexate—multiple sclerosis	7.4e-05	0.000653	CcSEcCtD
Abiraterone—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	7.36e-05	0.00201	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.32e-05	0.002	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MERTK—multiple sclerosis	7.04e-05	0.00192	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SELPLG—multiple sclerosis	7.04e-05	0.00192	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CD58—multiple sclerosis	7.04e-05	0.00192	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.93e-05	0.00189	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.83e-05	0.00186	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.83e-05	0.00186	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.73e-05	0.00184	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.73e-05	0.00184	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—ICAM1—multiple sclerosis	6.69e-05	0.00183	CbGpPWpGaD
Abiraterone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.64e-05	0.00181	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP27B1—multiple sclerosis	6.6e-05	0.0018	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP24A1—multiple sclerosis	6.6e-05	0.0018	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.45e-05	0.00176	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.28e-05	0.00172	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	6.26e-05	0.00171	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GPC5—multiple sclerosis	6.04e-05	0.00165	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—CCL2—multiple sclerosis	5.99e-05	0.00163	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.73e-05	0.00156	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SRM—multiple sclerosis	5.65e-05	0.00154	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	5.58e-05	0.00152	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.48e-05	0.0015	CbGpPWpGaD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.45e-05	0.00149	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—BCHE—multiple sclerosis	5.42e-05	0.00148	CbGpPWpGaD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.39e-05	0.00147	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	5.32e-05	0.00145	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.18e-05	0.00141	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IFNG—multiple sclerosis	5.09e-05	0.00139	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—RRM1—multiple sclerosis	5e-05	0.00137	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.97e-05	0.00136	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.88e-05	0.00133	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.88e-05	0.00133	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.86e-05	0.00133	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.86e-05	0.00133	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.84e-05	0.00132	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	4.76e-05	0.0013	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL1B—multiple sclerosis	4.54e-05	0.00124	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL2—multiple sclerosis	4.52e-05	0.00124	CbGpPWpGaD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.42e-05	0.00121	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GPC5—multiple sclerosis	4.35e-05	0.00119	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PLEK—multiple sclerosis	4.35e-05	0.00119	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	4.05e-05	0.00111	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	4.04e-05	0.0011	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP27B1—multiple sclerosis	3.98e-05	0.00109	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP24A1—multiple sclerosis	3.98e-05	0.00109	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.89e-05	0.00106	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.88e-05	0.00106	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.76e-05	0.00103	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GPC5—multiple sclerosis	3.64e-05	0.000994	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.61e-05	0.000985	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.57e-05	0.000973	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.33e-05	0.00091	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TNF—multiple sclerosis	3.3e-05	0.0009	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	3.27e-05	0.000892	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—APOE—multiple sclerosis	3.26e-05	0.000889	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SRM—multiple sclerosis	3.09e-05	0.000843	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SRM—multiple sclerosis	3.07e-05	0.000838	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SELE—multiple sclerosis	3.06e-05	0.000836	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.04e-05	0.00083	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—TGFB1—multiple sclerosis	3.03e-05	0.000826	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—RRM1—multiple sclerosis	3.02e-05	0.000824	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.97e-05	0.000812	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.93e-05	0.000801	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.89e-05	0.000789	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.88e-05	0.000787	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—BCHE—multiple sclerosis	2.87e-05	0.000785	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.86e-05	0.000781	CbGpPWpGaD
Abiraterone—ABCC1—Disease—RPL5—multiple sclerosis	2.83e-05	0.000772	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—POMC—multiple sclerosis	2.8e-05	0.000764	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SLC11A1—multiple sclerosis	2.71e-05	0.00074	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL6—multiple sclerosis	2.66e-05	0.000726	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.63e-05	0.000718	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.62e-05	0.000715	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ALB—multiple sclerosis	2.55e-05	0.000697	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SRM—multiple sclerosis	2.53e-05	0.000692	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.35e-05	0.000641	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.34e-05	0.000639	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—ITGA4—multiple sclerosis	2.21e-05	0.000605	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IFNB1—multiple sclerosis	2.2e-05	0.0006	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.17e-05	0.000594	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.17e-05	0.000594	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD28—multiple sclerosis	2.16e-05	0.000591	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP24A1—multiple sclerosis	2.16e-05	0.00059	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP27B1—multiple sclerosis	2.16e-05	0.00059	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.13e-05	0.00058	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.11e-05	0.000577	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.11e-05	0.000577	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.01e-05	0.000549	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.99e-05	0.000543	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GPC5—multiple sclerosis	1.98e-05	0.00054	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.83e-05	0.000501	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.79e-05	0.000487	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.79e-05	0.000487	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.74e-05	0.000476	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—BCHE—multiple sclerosis	1.73e-05	0.000473	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—APOE—multiple sclerosis	1.73e-05	0.000472	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.72e-05	0.00047	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SRM—multiple sclerosis	1.66e-05	0.000452	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.65e-05	0.00045	CbGpPWpGaD
Abiraterone—ALB—Metabolism—RRM1—multiple sclerosis	1.64e-05	0.000447	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.63e-05	0.000446	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD86—multiple sclerosis	1.54e-05	0.000421	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.54e-05	0.000419	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2RA—multiple sclerosis	1.51e-05	0.000413	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—POMC—multiple sclerosis	1.49e-05	0.000405	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CCR5—multiple sclerosis	1.37e-05	0.000374	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ALB—multiple sclerosis	1.35e-05	0.00037	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.35e-05	0.000369	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.34e-05	0.000366	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HLA-A—multiple sclerosis	1.33e-05	0.000364	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.32e-05	0.000359	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.28e-05	0.000349	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.27e-05	0.000347	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APOE—multiple sclerosis	1.25e-05	0.00034	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.17e-05	0.000319	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.17e-05	0.000319	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD80—multiple sclerosis	1.13e-05	0.000307	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.1e-05	0.0003	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.09e-05	0.000298	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.07e-05	0.000291	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOE—multiple sclerosis	1.04e-05	0.000285	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1e-05	0.000273	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TYK2—multiple sclerosis	9.5e-06	0.000259	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—BCHE—multiple sclerosis	9.47e-06	0.000258	CbGpPWpGaD
Abiraterone—ALB—Metabolism—BCHE—multiple sclerosis	9.41e-06	0.000257	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—POMC—multiple sclerosis	8.96e-06	0.000245	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—multiple sclerosis	8.87e-06	0.000242	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.85e-06	0.000242	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD4—multiple sclerosis	8.59e-06	0.000235	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALB—multiple sclerosis	8.17e-06	0.000223	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.77e-06	0.000212	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—multiple sclerosis	6.92e-06	0.000189	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK1—multiple sclerosis	6.78e-06	0.000185	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—multiple sclerosis	6.65e-06	0.000182	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—multiple sclerosis	6.18e-06	0.000169	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—multiple sclerosis	6.17e-06	0.000168	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK1—multiple sclerosis	6.05e-06	0.000165	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOE—multiple sclerosis	5.69e-06	0.000155	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOE—multiple sclerosis	5.66e-06	0.000155	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.08e-06	0.000139	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—POMC—multiple sclerosis	4.89e-06	0.000134	CbGpPWpGaD
Abiraterone—ALB—Metabolism—POMC—multiple sclerosis	4.86e-06	0.000133	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOE—multiple sclerosis	4.67e-06	0.000128	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—multiple sclerosis	4.65e-06	0.000127	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALB—multiple sclerosis	4.46e-06	0.000122	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—POMC—multiple sclerosis	4.02e-06	0.00011	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALB—multiple sclerosis	3.66e-06	0.0001	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOE—multiple sclerosis	3.06e-06	8.34e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—POMC—multiple sclerosis	2.63e-06	7.17e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALB—multiple sclerosis	2.39e-06	6.54e-05	CbGpPWpGaD
